Company intelligence / Profile preview
HONYA Medical
Tainan City, Tainan, Taiwanhonya-m.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
HONYA Medical is developing advanced stem cell therapies targeting cardiovascular and degenerative conditions. Their lead programs are in early clinical stages, with at least one program in Phase 1/2 for acute myocardial infarction and another in Phase 1 for coronary artery disease. The company leverages proprietary technologies to create personalized, ethically sourced stem cell products manufactured under GTP/GMP standards. No published late-stage or commercial results as of the latest update.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Stem cell therapyTissue engineering
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on HONYA Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HONYA Medical.